PROCAR
Harpoon Therapeutics, Inc.
Mark For: PROCAR™ trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 88168274 |
| Mark Literal Elements | PROCAR |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK. SERVICE MARK |
| Register | PRINCIPAL |
| Current Location | INTENT TO USE SECTION 2019-08-27 |
| Basis | 1(b) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | Yes |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Christine K. Au-Yeung |
| Attorney Docket Number | 47517-TM1012 |
| Law Office Assigned | N90 |
| Employee Name | SABAGH, LAILA TAREK |
Timeline
| 2018-10-24 | Application Filed |
| 2019-07-02 | Published |
| 2019-07-02 | Published for Opposition |
| 2019-08-27 | Location: INTENT TO USE SECTION |
| 2019-08-27 | Status: Live/Pending |
| 2019-08-27 | Transaction Date |
| 2021-02-02 | Status: A third request for extension of time to file a Statement of Use has been granted. |
Trademark Parties (Applicants & Owners)
| Party: |  Harpoon Therapeutics, Inc. |
| Address | 4000 Shoreline Court, Suite 250 South San Francisco, CALIFORNIA UNITED STATES 94080 |
| Legal Entity Type | Corporation |
| Legal Entity State | DELAWARE |
Documents
 Drawing | JPEG | 2018-10-24 |
 TEAS RF New Application | MULTI | 2018-10-24 |
| XSearch Search Summary | XML | 2019-01-31 |
| XSearch Search Summary | XML | 2019-02-01 |
| Notation to File | XML | 2019-02-07 |
| Priority Action | XML | 2019-02-07 |
| Notation to File | XML | 2019-05-09 |
| Examiners Amendment | XML | 2019-05-14 |
| Amendment and Mail Process Complete | MULTI | 2019-05-15 |
| TRAM Snapshot of App at Pub for Oppostn | MULTI | 2019-05-15 |
| Notice of Publication | XML | 2019-06-12 |
| Notification Of Notice of Publication | XML | 2019-06-12 |
| OG Publication Confirmation | APPLICATION/XML | 2019-07-02 |
| Notice of Allowance | APPLICATION/XML | 2019-08-27 |
| Extension of Time to File SOU | APPLICATION/XML | 2020-01-10 |
| ITU Extension Approval | APPLICATION/XML | 2020-01-14 |
| ITU Unit Action | APPLICATION/XML,IMAGE/JPEG | 2020-01-14 |
| Extension of Time to File SOU | APPLICATION/XML | 2020-07-20 |
| ITU Extension Approval | XML | 2020-07-22 |
| ITU Unit Action | APPLICATION/XML,IMAGE/JPEG | 2020-07-22 |
| Extension of Time to File SOU | APPLICATION/XML | 2021-02-02 |
| ITU Extension Approval | APPLICATION/XML | 2021-02-04 |
| ITU Unit Action | APPLICATION/XML,IMAGE/JPEG | 2021-02-04 |
Attorney of Record
Good, Services, and Codes
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations for T Cell therapy; pharmaceutical products for the prevention and treatment of cancer; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer and tumors; biological preparations for the treatment of cancer and tumors; biotechnological platform technology, namely, biotechnological, diagnostic, and therapeutic preparations in the form of antibodies for delivery to cells in T cell therapy and treatment of cancer
IC 042. US 100 101. G & S: Pharmaceutical research and development
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations for T Cell therapy; pharmaceutical products for the prevention and treatment of cancer; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer and tumors; biological preparations for the treatment of cancer and tumors; biotechnological platform technology, namely, biotechnological, diagnostic, and therapeutic preparations in the form of antibodies for delivery to cells in T cell therapy and treatment of cancer |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2021-02-04 | |
| TEAS EXTENSION RECEIVED | 2021-02-02 | |
| EXTENSION 3 GRANTED | 2021-02-02 | 98765 |
| EXTENSION 3 FILED | 2021-02-02 | 98765 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-07-22 | |
| TEAS EXTENSION RECEIVED | 2020-07-20 | |
| EXTENSION 2 GRANTED | 2020-07-20 | 98765 |
| EXTENSION 2 FILED | 2020-07-20 | 98765 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-01-14 | |
| TEAS EXTENSION RECEIVED | 2020-01-10 | |
| EXTENSION 1 GRANTED | 2020-01-10 | 98765 |
| EXTENSION 1 FILED | 2020-01-10 | 98765 |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2019-08-27 | |
| PUBLISHED FOR OPPOSITION | 2019-07-02 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-07-02 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-06-12 | |
| ASSIGNED TO LIE | 2019-05-29 | 66121 |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2019-05-14 | 6328 |
| EXAMINERS AMENDMENT E-MAILED | 2019-05-14 | 6328 |
| EXAMINERS AMENDMENT -WRITTEN | 2019-05-14 | 94365 |
| EXAMINER'S AMENDMENT ENTERED | 2019-05-14 | 88888 |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-05-14 | |
| PRIORITY ACTION WRITTEN | 2019-02-07 | 94365 |
| PRIORITY ACTION E-MAILED | 2019-02-07 | 6326 |
| NOTIFICATION OF PRIORITY ACTION E-MAILED | 2019-02-07 | 6326 |
| ASSIGNED TO EXAMINER | 2019-01-31 | 94365 |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-11-07 | |
| NEW APPLICATION ENTERED IN TRAM | 2018-10-27 |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 